tiprankstipranks
Cabaletta Bio Reveals Insights in Updated Corporate Presentation
PremiumCompany AnnouncementsCabaletta Bio Reveals Insights in Updated Corporate Presentation
2M ago
Cabaletta Bio reports Q1 EPS (51c) , consensus (48c)
PremiumThe Fly
Cabaletta Bio reports Q1 EPS (51c) , consensus (48c)
2M ago
Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update
PremiumPress Releases
Cabaletta Bio Reports First Quarter 2024 Financial Results and Provides Business Update
2M ago
Cabaletta Bio price target lowered to $34 from $35 at Wells Fargo
PremiumThe FlyCabaletta Bio price target lowered to $34 from $35 at Wells Fargo
3M ago
Cabaletta Bio price target raised to $30 from $25 at H.C. Wainwright
PremiumThe Fly
Cabaletta Bio price target raised to $30 from $25 at H.C. Wainwright
3M ago
Cabaletta Bio price target raised to $32 from $31 at Stifel
PremiumThe Fly
Cabaletta Bio price target raised to $32 from $31 at Stifel
3M ago
Cabaletta Bio granted Orphan Drug designation to CABA-201
PremiumThe FlyCabaletta Bio granted Orphan Drug designation to CABA-201
3M ago
Cabaletta Bio treatment of systemic sclerosis granted orphan designation
PremiumThe Fly
Cabaletta Bio treatment of systemic sclerosis granted orphan designation
3M ago
Cabaletta Bio, Inc. (CABA) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Cabaletta Bio, Inc. (CABA) Q4 Earnings Cheat Sheet
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100